Rankings
▼
Calendar
RLAY Q3 2025 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
RLAY
Relay Therapeutics, Inc.
$2B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$748,000
Operating Income
-$80M
Net Income
-$74M
EPS (Diluted)
$-0.43
QoQ Revenue Growth
-100.0%
Cash Flow
Operating Cash Flow
-$62M
Free Cash Flow
-$62M
Stock-Based Comp.
$16M
Balance Sheet
Total Assets
$670M
Total Liabilities
$62M
Stockholders' Equity
$608M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$748,000
$0
—
Operating Income
-$80M
-$96M
+16.6%
Net Income
-$74M
-$88M
+15.8%
← FY 2025
All Quarters
Q4 2025 →